Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature
- First Online:
Current treatments for benign prostatic hyperplasia (BPH) include watchful waiting, medical therapy, and interventional procedures. The post-surgical complication profile and the early discontinuation of medical therapy are significant drawbacks of the established approach and stimulate the search for less-invasive approaches. Our aim is to provide a comprehensive review all available literature on prostatic urethral lift (PUL), presenting an overview of safety, indications, surgical technique and results of the procedure, and to evaluate the potential role it could play in the treatment of BPH. A comprehensive search was conduct on PubMed and Scopus database to identify original articles in English dealing with PUL without any limit to publication date. Keywords used were prostatic urethral lift, urethral lifting, Urolift, benign prostatic hyperplasia and minimally invasive therapy. The PUL seems to offer a better IPSS improvement when compared to medical therapy, but the result is inferior when compared to surgical therapy. Published studies report an absence of degradation of erectile or ejaculatory function after treatment, which appears a noteworthy benefit of PUL. Additional advantages of the PUL are a better complication profile in comparison to other surgical therapies and the use of a local anesthesia, sometimes without postoperative catheterization. The PUL, a novel, minimally invasive treatment option for men affected by BPH, presents a promising potential although it is clear that PUL is not a substitute for traditional ablative surgical approach, as this procedure requires a scrupulous selection of the patient.
KeywordsUrethral lift Benign prostatic hyperplasia Lower urinary tract symptoms Transurethral resection of the prostate Prostatic urethral lift
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 2.Oelke M, Bachmann M, Descazeaud A, Emberton M, Gravas S, Michel MC, N’Dow J, Nordling J, de la Rosette JJ. Guidelines on Management of Male Lower Urinary Tract Symptoms (LUTS), incl. Benign Prostatic Obstruction (BPO). European Association of Urology Guidelines–2012; 2012.Google Scholar
- 4.• Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, et al. Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol. 2010;58:384–97. An exhaustive review that offers a global evaluation of the surgical therapies for BPH. TURP, bipolar TURP, transurethral vaporisation of the prostate, Holep, and potassium-titanyl-phosphate laser vaporisation of the prostate are evaluated in terms of results and complications.PubMedCrossRefGoogle Scholar
- 9.Woo HH, Chin PT, McNicholas TA, Gill HS, Plante MK, Bruskewitz RC, et al. Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). BJU Int. 2011;108:82–8.PubMedCrossRefGoogle Scholar
- 10.• Barkin J, Giddens J, Incze P, Casey R, Richardson S, Gange S. UroLift system for relief of prostate obstruction under local anesthesia. Can J Urol. 2012;19:6217–22. Surgery-in-motion like paper that provide details about technical aspects of the procedure. Useful for who wants to start with the device.PubMedGoogle Scholar
- 11.• Woo HH, Bolton DM, Laborde E, Jack G, Chin PT, Rashid P, et al. Preservation of sexual function with the prostatic urethral lift: a novel treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Sex Med. 2012;9:568–75. Original article reporting the main PUL patient series. The paper emphasizes the results of the procedure in terms of sexual function.PubMedCrossRefGoogle Scholar
- 12.• Chin PT, Bolton DM, Jack G, Rashid P, Thavaseelan J, Yu RJ, et al. Prostatic urethral lift: two-year results after treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urology. 2012;79:5–11. Original article reporting the main PUL patient series. The paper showes the results of the procedure at the longest follow up available.PubMedCrossRefGoogle Scholar
- 19.Roehrborn CG, Siami P, Barkin J, Damiao R, Major-Walker K, Nandy I, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57:123–31.PubMedCrossRefGoogle Scholar
- 23.BPH-6: Comparison of the UroLift System to Transurethral Resection of the Prostate (TURP) for Benign Prostatic Hyperplasia–Idnetifier NCT01533038. http://clinicaltrials.gov/show/NCT01533038.